Back to top

Genenta Announces Long-Term Follow-Up Observations in Brain Tumor (GBM) Study with Emerging ...

Genenta Announces Long-Term Follow-Up Observations in Brain Tumor (GBM) Study with Emerging Survival Signals | GNTA Stock News

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Genenta Science S.p.A. Unsponsored ADR (GNTA)